Zhong Lun advised Lepu Bio on the deal while Sidley represented Keymed Biosciences. Lepu Biopharma Co., Ltd and Keymed Biosciences Inc. signed a global exclusive license agreement...
You must be a Standard 1 Year member to access this content.
Sidley advised Akeso Inc. on the deal. Akeso Inc. announced a high-profile US$5 billion collaboration and licensing agreement with Summit Therapeutics Inc. to out-license its breakthrough bispecific...
You must be a Standard 1 Year member to access this content.
Sidley represented Myovant Sciences on the deal. Pinsent Masons represented Accord Healthcare. Myovant Sciences (NYSE: MYOV), a biopharmaceutical company focused on developing innovative treatments for women’s...
You must be a Standard 1 Year member to access this content.
